Pier 88 Investment Partners LLC Iovance Biotherapeutics, Inc. Transaction History
Pier 88 Investment Partners LLC
- $62.9 Million
- Q1 2024
A detailed history of Pier 88 Investment Partners LLC transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Pier 88 Investment Partners LLC holds 22,900 shares of IOVA stock, worth $167,170. This represents 0.54% of its overall portfolio holdings.
Number of Shares
22,900
Previous 27,290
16.09%
Holding current value
$167,170
Previous $221,000
53.39%
% of portfolio
0.54%
Previous 0.34%
Shares
10 transactions
Others Institutions Holding IOVA
# of Institutions
305Shares Held
221MCall Options Held
3.05MPut Options Held
1.6M-
Vanguard Group Inc Valley Forge, PA24.9MShares$182 Million0.01% of portfolio
-
Mhr Fund Management LLC New York, NY24MShares$175 Million40.86% of portfolio
-
Black Rock Inc. New York, NY19.9MShares$145 Million0.01% of portfolio
-
Perceptive Advisors LLC New York, NY19.3MShares$141 Million5.99% of portfolio
-
Avoro Capital Advisors LLC New York, NY11.7MShares$85.4 Million2.09% of portfolio
About IOVANCE BIOTHERAPEUTICS, INC.
- Ticker IOVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 157,800,992
- Market Cap $1.15B
- Description
- Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...